Emerging methods may help reveal health of individual eye cells

NewsGuard 100/100 Score

Researchers are studying ways to get a snapshot of all the genetic material that a single retina cell uses to make proteins, revealing the health of that eye cell. The research is being presented at the 2015 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) this week in Denver, Colo.

Using a mouse model, scientists looked at the rod cells in the retina, which function in low light. They used two different methods to evaluate the genetic material, one of which detected more genes in the cell but cost significantly higher.

Continued refinement of these techniques may result in a simple, cost-effective way for researchers to look at the health of individual eye cells in a person with retinal disease. Revealing how young cells are different from old cells or how healthy cells are different from diseased cells could provide the foundation for more effective eye treatments.

Abstract Title: Transcriptome profiling of single rod photoreceptors in the Rd1 mouse
Presentation Start/End Time: Thursday, May 7, 8:30 - 10:15am
Location: Exhibit Hall
Abstract Number: 5499 - B0058

Source: Association for Research in Vision and Ophthalmology

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Fluent BioSciences awarded NIH SBIR grant to commercialize low-cost million-cell transcriptome profiling kits